These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19133704)

  • 1. Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies.
    Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P
    Clin Drug Investig; 2009; 29(2):87-100. PubMed ID: 19133704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.
    Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P
    Drugs Aging; 2011 Feb; 28(2):139-50. PubMed ID: 21275439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies.
    Darwish M; Kirby M; Hellriegel ET; Robertson P
    Clin Drug Investig; 2009; 29(9):613-23. PubMed ID: 19663523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of steady-state plasma concentrations of armodafinil and modafinil late in the day following morning administration: post hoc analysis of two randomized, double-blind, placebo-controlled, multiple-dose studies in healthy male subjects.
    Darwish M; Kirby M; Hellriegel ET
    Clin Drug Investig; 2009; 29(9):601-12. PubMed ID: 19663522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects.
    Darwish M; Kirby M; Robertson P; Hellriegel ET
    Clin Pharmacokinet; 2008; 47(1):61-74. PubMed ID: 18076219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss.
    Dinges DF; Arora S; Darwish M; Niebler GE
    Curr Med Res Opin; 2006 Jan; 22(1):159-67. PubMed ID: 16393442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites.
    Willavize S; Fiedler-Kelly J; Ludwig E; Guan L
    J Clin Pharmacol; 2017 Feb; 57(2):255-265. PubMed ID: 27436172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers.
    Wong YN; Simcoe D; Hartman LN; Laughton WB; King SP; McCormick GC; Grebow PE
    J Clin Pharmacol; 1999 Jan; 39(1):30-40. PubMed ID: 9987698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study.
    Darwish M; Kirby M; D'Andrea DM; Yang R; Hellriegel ET; Robertson P
    Clin Ther; 2010 Nov; 32(12):2074-87. PubMed ID: 21118743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships.
    Darwish M; Bond M; Ezzet F
    J Clin Pharmacol; 2012 Sep; 52(9):1328-42. PubMed ID: 22039290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression.
    Niemegeers P; Maudens KE; Morrens M; Patteet L; Joos L; Neels H; Sabbe BG
    Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1189-97. PubMed ID: 22803602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Armodafinil for excessive daytime sleepiness.
    Nishino S; Okuro M
    Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR; Khan A; McCall WV; Weintraub J; Tiller J
    J Clin Sleep Med; 2010 Oct; 6(5):450-7. PubMed ID: 20957845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Armodafinil in the treatment of excessive sleepiness.
    Bogan RK
    Expert Opin Pharmacother; 2010 Apr; 11(6):993-1002. PubMed ID: 20307223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of modafinil tablets in Chinese subjects.
    Xu P; Li HD; Zhang BK; Xiao YW; Yuan HY; Zhu YG
    J Clin Pharm Ther; 2008 Aug; 33(4):429-37. PubMed ID: 18613861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the potential for a pharmacokinetic drug-drug interaction between armodafinil and ziprasidone in healthy adults.
    Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P
    Clin Drug Investig; 2014 Oct; 34(10):691-9. PubMed ID: 25047407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE; Hull SG; Tiller J; Yang R; Harsh JR
    J Clin Sleep Med; 2010 Oct; 6(5):458-66. PubMed ID: 20957846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.
    Wong YN; King SP; Simcoe D; Gorman S; Laughton W; McCormick GC; Grebow P
    J Clin Pharmacol; 1999 Mar; 39(3):281-8. PubMed ID: 10073328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Armodafinil: a new treatment for excessive sleepiness.
    Lankford DA
    Expert Opin Investig Drugs; 2008 Apr; 17(4):565-73. PubMed ID: 18363520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.
    Czeisler CA; Walsh JK; Wesnes KA; Arora S; Roth T
    Mayo Clin Proc; 2009 Nov; 84(11):958-72. PubMed ID: 19880686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.